BioinksBioprinting

Puredyne and Humabiologics to provide integrated bioprinting solution

Strategic partnership seeks to improve printing processes with biomaterials such as collagen and gelatin using Puredyne kit b

Stay up to date with everything that is happening in the wonderful world of AM via our LinkedIn community.

Puredyne has formed a strategic partnership with Humabiologics that is set to benefit researchers when it comes to printing collagen and gelatin. The collaboration between the two companies provides scientists with an integrated solution of printing precision through Puredyne kit b and the clinical relevance of Humabiologics human bioinks.

Humabiologics is a rapidly growing US regenerative medicine company based in Phoenix, Arizona focused on providing native human-derived collagen, gelatin, and extracellular matrices from donated human tissue. Humabiologics offers a number of products including HumaDerm, the most affordable native human skin collagen type I, and Huma OsteoGelMA, the market’s first native human gelatin methacrylate (GelMA). Their products are manufactured under an ISO 13845 quality system and comply with GMP standards, to provide researchers with the highest quality and clinically relevant solutions to support the development of translational regenerative therapies and drug discovery.

With a core mission to honor the gift of donated human tissue, Humabiologics promotes translational scientific advancements in biomaterials and 3D printing to develop lifesaving therapies and enhance treatments. By offering human biomaterials that are high quality, affordable, and in stable supply, it is their hope to accelerate translational medicine and empower tomorrow’s innovations.

Puredyne and Humabiologics form strategic partnership seeks to improve printing processes with biomaterials such as collagen and gelatin

The benefits of the collaboration between the two companies and the use of the Puredyne kit b are clear, as Humabiologics is now able to print human collagen and gelatin even more precisely – and thus also more cost-effectively.

“Puredyne’s printing platform has precise and impressive printing capabilities accommodating various bioink formulas with high fidelity. The plug-and-play print head addresses a number of common issues related to the bioink of choice with other printing platforms such as clogging, viscosity and concentration limitations, low cell viability, and other issues. We are excited to see the impact of such technologies for researchers around the globe.” says Madeline Damasco, Scientific Liaison at Humabiologics.

Printing biomaterials with high resolution to develop complex tissue models remains a challenge and a labor intensive process. In addition, the volume of the bioink that is used in the printing process is often more than the volume needed to print the structure. This is mainly due to volume lost in channels of the dispensing platform including the bioink cartridge. Puredyne’s platform addresses these challenges through the progressive cavity technology used in the cartridge, which not only overcomes the different viscosity challenges, but also reduces the volume of bioink needed and reduces the cost.

“Our partnership with Humabiologics will advance the bioprinting sector as a whole. With the combined advantages of the Puredyne portfolio, and Humabiologics superior biomaterials, companies and universities will achieve reproducible research results and higher cell viability,” said Annaliese Vojnich, Business Development Manager at ViscoTec America

For users, a key highlight is the fact that the Puredyne kit b is very easy to use. When comparable technologies need complex process control systems, the Puredyne kit b sets itself apart by intuitively linking the screw’s rotating speed to the material flow rate in a linear relationship.

Research
Composites AM 2024

746 composites AM companies individually surveyed and studied. Core composites AM market generated over $785 million in 2023. Market expected to grow to $7.8 billion by 2033 at 25.8% CAGR. This new...

Davide Sher

Since 2002, Davide has built up extensive experience as a technology journalist, market analyst and consultant for the additive manufacturing industry. Born in Milan, Italy, he spent 12 years in the United States, where he completed his studies at SUNY USB. As a journalist covering the tech and videogame industry for over 10 years, he began covering the AM industry in 2013, first as an international journalist and subsequently as a market analyst, focusing on the additive manufacturing industry and relative vertical markets. In 2016 he co-founded London-based VoxelMatters. Today the company publishes the leading news and insights websites VoxelMatters.com and Replicatore.it, as well as VoxelMatters Directory, the largest global directory of companies in the additive manufacturing industry.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button
Close Popup
Privacy Settings saved!
Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

Technical Cookies
In order to use this website we use the following technically required cookies
  • PHPSESSID
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec

Decline all Services
Save
Accept all Services

Newsletter

Join our 12,000+ Professional community and get weekly AM industry insights straight to your inbox. Our editor-curated newsletter equips executives, engineers, and end-users with crucial updates, helping you stay ahead.